# Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)

> **NCT00906022** · PHASE4 · COMPLETED · sponsor: **Biotronik AG** · enrollment: 94 (actual)

## Conditions studied

- Patients With Symptomatic Critical Limb Ischemia
- Severe Intermittent Claudication

## Interventions

- **DEVICE:** Astron Pulsar Stent
- **DEVICE:** PTA alone

## Key facts

- **NCT ID:** NCT00906022
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2015-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906022, "Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00906022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*